Protective and anti-inflammatory effect of a traditional Chinese medicine, Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury

International Immunopharmacology

Volumn 6, Issue 9, 2006, Pages 1506-1514

  Yeh, Chia Chou ^a,b   Lin, Chih Che ^a   Wang, Shulhn Der ^a   Chen, Yueh Sheng ^a   Su, Bai Horng ^a   Kao, Shung Te ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Wei Gong Memorial Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti inflammatory cytokines; Chemokines; iNOS; LPS; NF B; Proinflammatory cytokines

Indexed keywords

CHEMOKINE; CHINESE DRUG; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PEPTIDE 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; PROTEIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XIA BAI SAN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; LUNG; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT EXTRACTS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33745858359     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.04.015     Document Type: Article

References (36)

1. Dreyfuss D., and Ricard J.D. Acute lung injury and bacterial infection. Clin. Chest. Med. 26 (2005) 105-112
2. Kollef M.H., and Schuster D.P. The acute respiratory distress syndrome. N. Engl. J. Med. 332 (1995) 27-37
3. Abraham E., Carmody A., Shenkar R., and Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol., Lung Cell. Mol. Physiol. 279 (2000) L1137-L1145
4. Chignard M., and Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am. J. Physiol., Lung Cell Mol. Physiol. 279 (2000) L1083-L1090
5. Goodman R.B., Pugin J., Lee J.S., and Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14 (2003) 523-535
6. Shinbori T., Walczak H., and Krammer P.H. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-alpha. Eur. J. Immunol. 34 (2004) 1762-1770
7. Wright R.M., Ginger L.A., Kosila N., Elkins N.D., Essary B., McManaman J.L., et al. Mononuclear phagocyte xanthine oxidoreductase contributes to cytokine-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 30 (2004) 479-490
8. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94 (1994) 2407-2413
9. Matthay M.A., Geiser T., Matalon S., and Ischiropoulos H. Oxidant-mediated lung injury in the acute respiratory distress syndrome. Crit. Care Med. 27 (1999) 2028-2030
10. Sato K., Kadiiska M.B., Ghio A.J., Corbett J., Fann Y.C., Holland S.M., et al. In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB J. 16 (2002) 1713-1720
11. Borron P., McIntosh J.C., Korfhagen T.R., Whitsett J.A., Taylor J., and Wright J.R. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol., Lung Cell. Mol. Physiol. 278 (2000) L840-L847
12. Harrod K.S., Mounday A.D., and Whitsett J.A. Adenoviral E3-14.7K protein in LPS-induced lung inflammation. Am. J. Physiol., Lung Cell. Mol. Physiol. 278 (2000) L631-L639
13. Heflin Jr. A.C., and Brigham K.L. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68 (1981) 253-1260
14. Puneet P., Moochhala S., and Bhatia M. Chemokines in acute respiratory distress syndrome. Am. J. Physiol., Lung Cell. Mol. Physiol. 288 (2005) L3-L15
15. Gerard C., Frossard J.L., Bhatia M., Saluja A., Gerard N.P., Lu B., et al. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100 (1997) 2022-2027
16. Agouridakis P., Kyriakou D., Alexandrakis M.G., Prekates A., Perisinakis K., Karkavitsas N., et al. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir. Res. 3 (2002) 25
17. Meduri G.U. Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Crit. Care 6 (2002) 24-29
18. Goodman R.B., Pugin J., Lee J.S., and Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14 (2003) 523-535
19. Donnelly S.C., Strieter R.M., Reid P.T., Kunkel S.L., Burdick M.D., Armstrong I., et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 125 (1996) 191-196
20. Lynch E.L., Little F.F., Wilson K.C., Center D.M., and Cruikshank W.W. Immunomodulatory cytokines in asthmatic inflammation. Cytokine Growth Factor Rev. 14 (2003) 489-502
21. Skerrett S.J., Liggitt H.D., Hajjar A.M., Ernst R.K., Miller S.I., and Wilson C.B. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am. J. Physiol., Lung Cell. Mol. Physiol. 287 (2004) L143-L152
22. Qu J., Zhang J., Pan J., He L., Ou Z., Zhang X., et al. Endotoxin tolerance inhibits lipopolysaccharide-initiated acute pulmonary inflammation and lung injury in rats by the mechanism of nuclear factor-kappaB. Scand J Immunol 58 (2003) 613-619
23. Martin T.R. Recognition of bacterial endotoxin in the lungs. Am. J. Respir. Cell Mol. Biol. 23 (2000) 128-132
24. Martin T.R., Mathison J.C., Tobias P., Leturcq D.J., Moriarty A.M., Maunder R.J., et al. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J. Clin. Invest. 90 (1992) 2209-2219
25. Li Q., and Verma I.M. NF-κB regulation in the immune system. Nat. Rev., Immunol. 2 (2002) 725-734
26. Tsai W.C., Strieter R.M., Wilkowski J.M., Bucknell K.A., Burdick M.D., Lira S.A., et al. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 161 (1998) 2435-2440
27. Sadikot R.T., Han W., Everhart M.B., Zoia O., Peebles R.S., Jansen E.D., et al. Selective IκB kinase expression in airway epithelium generates neutrophilic lung inflammation. J. Immunol. 170 (2003) 1091-1098
28. Wang X., Ebong S.J., Call D.R., Newcomb D.E., Bolgos G.R., and Remick D.G. Calcitonin gene-related peptide partially reverses decreased production of chemokines KC and MIP-2 following murine sepsis. Inflammation 26 (2002) 167-174
29. Jansson A.H., Eriksson C., and Wang X. Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats. Lung 182 (2004) 163-171
30. Varley A.W., Coulthard M.G., Meidell R.S., Gerard R.D., and Munford R.S. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc. Natl. Acad. Sci. 92 (1995) 5346-5350
31. Baetz D., Shaw J., and Kirshenbaum L.A. Nuclear factor-kappaB decoys suppress endotoxin-induced lung injury. Mol. Pharmacol. 67 (2005) 977-979
32. Saadane A., Soltys J., and Berger M. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice. J. Allergy Clin. Immunol. 115 (2005) 405-411
33. Wang P., Wu P., Siegel M.I., Egan R.W., and Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270 (1995) 9558-9563
34. Goodman R.B., Pugin J., Lee J.S., and Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14 (2003) 523-535
35. Zisman D.A., Kunkel S.L., Strieter R.M., Tsai W.C., Bucknell K., Wilkowski J., et al. MCP-1 protects mice in lethal endotoxemia. J. Clin. Invest. 99 (1997) 2832-2836
36. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187 (1998) 601-608